Promakhos Therapeutics
A therapeutics platform for curing inflammatory disorders
Operating in healthcare based in Boston, MA, USA, Promakhos Therapeutics operates.
Profile
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
Promakhos Therapeutics is positioned in healthcare, a segment that rewards a clear, focused offering.
Boston, MA, USA is where the company is located.
The company is listed at the Summer 2021 stage of development.
The company reports a headcount in the 2 range.
| Sector | Healthcare |
|---|---|
| Headquarters | Boston, MA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Summer 2021 |
Website: www.promakhos.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account